Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DSP107 + Atezolizumab vs Fruquintinib in Advanced MSS Colorectal Cancer
NCT07235293Phase 2Recruiting
- Sponsor
- KAHR Medical
- Start
- Jan 2026
- Primary completion
- Sep 2026
- Modality
- Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 2 trial of DSP107 in colorectal cancer (CRC), sponsored by KAHR Medical. Started Jan 2026; status: recruiting.
02
Drugs
DSP107
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07235293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07235293.